Medical/Pharmaceuticals
Compal Electronics Has Launched "AblatePal" RF Ablation System and "BreathePal" Bilevel Ventilator in Therapeutic Medical Device Market
TAIPEI, April 7, 2023 /PRNewswire/ -- Compal Electronics ("Compal"), a leading Taiwanese electronics company, has announced its expansion into the development of innovative therapeutic medical devices. Compal has launched a new radiofrequency ablation (RFA) system for percutaneous, intraoperative...
2023-04-07 09:00
3694
BGI Global Colorectal Cancer Survey Reveals Awareness Gaps and Affordability Concerns
HONG KONG, April 7, 2023 /PRNewswire/ -- To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics today released its State of Colorectal Cancer Awareness Report, marking the first-ever global survey report on the world's third most commo...
2023-04-07 08:27
4029
Dymax Reveals MD® 1045-M Multipurpose Adhesive for Prefilled Syringes and Injection Devices
UV/LED Curable Material Exhibits Very Low Extractables SINGAPORE, April 6, 2023 /PRNewswire/ -- Dymax, a leading manufacturer of rapid-curing materials and equipment, is pleased to announce the release of 1045-M adhesive, the newest product in its renowned line of MD® light-curable materials for...
2023-04-06 10:10
2405
Everest Medicines Announces New Drug Application Acceptance by Singapore HSA for Nefecon for the Treatment of Primary IgA Nephropathy
Nefecon NDA is currently under Priority Review in China and expected to receive
approval in 2H 2023
SHANGHAI, April 6, 2023 /PRNewswire/ -- Everest Medicines
2023-04-06 07:30
2672
Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia
KUALA LUMPUR, Malaysia, April 5, 2023 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today announced that it has entered an agreement with Duopharma Marketing Sdn Bhd, a wholly-owned ...
2023-04-05 10:44
4283
RS Abdi Waluyo acquires the world's first photon-counting CT to improve clinical outcomes for patients in Indonesia
* NAEOTOM Alpha is world's first CT scanner with photon-counting technology. * RS Abdi Waluyo will be first hospital in Indonesia to offer patients the benefits of photon-counting technology. JAKARTA, Indonesia, April 5, 2023 /PRNewswire/ -- RSAbdi Waluyo located in Jakarta will be the first h...
2023-04-05 10:00
4185
Bridgewest Group launches NovaCina, new sterile injectable CDMO
MIAMI and PERTH, Australia, April 5, 2023 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, launches new Contract Development and Manufacturing Organization (CDMO) focused on sterile injectabl...
2023-04-05 09:41
2228
Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
Sale of Indivumed's Service Business to Crown Bioscience Enables Creation of Oncology R&D Powerhouse HAMBURG, Germany, April 5, 2023 /PRNewswire/ -- After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics after t...
2023-04-05 07:00
2360
Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing
PLANTATION, Fla., April 4, 2023 /PRNewswire/ -- GBI proudly announces the signing of their first Master Supply Agreement for commercializing an antibody. With the development of this new partnership, GBI's integrated CDMO biologics services will showcase their expertise in bringing a product from...
2023-04-04 20:57
2263
Metabolon Launches Bile Acids and Short Chain Fatty Acids Targeted Panels to Advance Understanding of Microbiome and Gut Metabolome in Health and Disease
Targeted metabolomics panels provide absolute quantitation for important bioactive intermediaries of the microbiome and gastrointestinal gut health MORRISVILLE, N.C., April 4, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety o...
2023-04-04 20:03
1916
Latest Updates of 6 Viva's Portfolio Companies
HONG KONG, April 4, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...
2023-04-04 19:39
2498
Cambrex Opens New Stability Storage Facility in Belgium
EAST RUTHERFORD, N.J., April 4, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Sc...
2023-04-04 15:00
2104
Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer
MIAMI and PERTH, Australia, April 4, 2023 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, announces that it has completed the acquisition of thePerth sterile injectable manufacturing facilit...
2023-04-04 10:00
2849
BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award
IRVINE, Calif., April 4, 2023 /PRNewswire/ -- Life Sciences Review magazine recognizes BioDuro-Sundia as top 10 Business Process Outsourcing (BPO). BioDuro-Sundia earned this award for its high-quality service and cutting-edge technology, as well as its integrated contract research, development a...
2023-04-04 08:30
2755
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects
HANGZHOU, China, April 4, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has recently completed phase I trials in healthy subjects inChina for its self-developed innovative intestina...
2023-04-04 08:00
2830
AAHRPP Accredits Two More Research Organizations, Including Another in China
WASHINGTON, April 1, 2023 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has accredited two more research organizations: a nonprofit health system in the American Midwest and another organization inChina. The newly accredited organizations are: * A...
2023-04-01 01:10
4867
Henlius 2022 Annual Results: Significant Achievements in Commercialisation, Surged to RMB3.2 Billion in Revenues
SHANGHAI, April 1, 2023 /PRNewswire/ -- Henlius (2696.HK) announced its 2022 annual results. In 2022, Henlius' revenue reached aboutRMB3.2147 billion, representing an increase of 91.1% YoY, primarily due to sales revenue and licensing revenue generated by the successive commercialisation of vario...
2023-04-01 00:06
9138
Dr. Pradeep Sethi of Eugenix Hair Sciences chosen scientific director at the prestigious 6th World FUE Institute 2023 Workshop in Thailand
- India on the cusp of becoming global capital of Hair Transplant BANGKOK, March 31, 2023 /PRNewswire/ -- Hair loss is a common problem that affects millions of people worldwide. Fortunately, advancements in technology and medicine have made hair restoration a viable option for many.Eugenix Hair...
2023-03-31 16:07
3101
Yunkang Group Announces First Annual Results Since Listing
Revenue increases by 121.4% to RMB 3,756 million Profit attributable to owners of the Company of RMB 377 million Three major businesses grow rapidly through in-depth service and lean management HONG KONG, March 31, 2023 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Cod...
2023-03-31 13:05
3652
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China
SHANGHAI, March 31, 2023 /PRNewswire/ -- Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients inChina, today announced the development plans of a first-in-class novel peptide drug candidate against GPC3. The proprietary GPC...
2023-03-31 10:00
2816
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Announcement of "Cyber Sousa Award" Winners of the 16th Xiamen International Animation Festival
[Picked up by 272 media titles]
2024-11-26 16:48
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12916
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
9000
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8155
